Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A randomised, double-blind, placebo-controlled, 3-period crossover study to assess the efficacy and safety of single dose intranasal GSK1004723 compared with placebo in an allergen challenge chamber in male subjects with seasonal allergic rhinitis
GSK1004723
HHI110159
NCT00824356
Rhinitis, Allergic, Seasonal
Phase 2
 
August 2015

Powered by ideaPoint, Inc.